HHS pledges $23M to develop Merck's experimental Ebola vaccine

HHS pledges $23M to develop Merck's experimental Ebola vaccine

Source: 
Beckers Hospital Review
snippet: 

In response to the Ebola outbreak in the Democtratic Republic of Congo, HHS will fund the development of Merck's investigational Ebola vaccine.

The department will give Merck $23 million to produce V920 doses over the next year and will work with the drugmaker to help secure FDA approval for the vaccine.